title: Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
authors.forename: M L
authors.initials: ML
authors.lastname: McSwain
authors.forename: L M
authors.initials: LM
authors.lastname: Forman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018697:Nootropic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000503:physiopathology; D013619:Tacrine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D018697:Nootropic Agents; D013619:Tacrine; D006220:Haloperidol